Literature DB >> 16049723

[Aftercare or not--that is the question!].

G Schubert-Fritschle1, L Weissbach, D Hölzel.   

Abstract

There are about 345,000 Germans who have been diagnosed with urological cancer over the last 5 years expecting help from the health services. Even if aftercare is now a substantial part of cancer treatment, its effectiveness has been proven for only a few cancer types. For the subset of urological cancers, evidence for effective diagnostic measures in the framework of aftercare exists only for cancers of the bladder and testis. In this case, the main objective is early detection of local recurrences and providing a curative chance for small cancers. Lack of effectiveness may result from the logic of cancer itself, and is not the consequence of insufficient study designs. Therefore, the main task of aftercare is talking to the patient, to determine individual needs and to recognise treatment consequences. For asymptomatic patients, there is no indication for routine aftercare diagnostics.

Entities:  

Mesh:

Year:  2005        PMID: 16049723     DOI: 10.1007/s00120-005-0878-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  8 in total

Review 1.  Follow-up strategies for women treated for early breast cancer.

Authors:  M P Rojas; E Telaro; A Russo; R Fossati; C Confalonieri; A Liberati
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  The role of complementary and alternative medicine.

Authors:  E Ernst
Journal:  BMJ       Date:  2000-11-04

3.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

Review 4.  Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Authors:  G M Jeffery; B E Hickey; P Hider
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 5.  [A tumor after-care schedule: information content--use--optimization].

Authors:  D Hölzel; H Sauer; J C de Waal
Journal:  Onkologie       Date:  1988-10

6.  Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients.

Authors:  J Kerr; J Engel; A Schlesinger-Raab; H Sauer; D Hölzel
Journal:  Ann Oncol       Date:  2003-03       Impact factor: 32.976

7.  Do cancer centers designated by the National Cancer Institute have better surgical outcomes?

Authors:  Nancy J O Birkmeyer; Philip P Goodney; Therese A Stukel; Bruce E Hillner; John D Birkmeyer
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

8.  The process of metastasisation for breast cancer.

Authors:  J Engel; R Eckel; J Kerr; M Schmidt; G Fürstenberger; R Richter; H Sauer; H-J Senn; D Hölzel
Journal:  Eur J Cancer       Date:  2003-08       Impact factor: 9.162

  8 in total
  1 in total

1.  Serotonin used as prognostic marker of urological tumors.

Authors:  Nina Jungwirth; Lothar Haeberle; Karl Michael Schrott; Bernd Wullich; Frens Steffen Krause
Journal:  World J Urol       Date:  2008-06-26       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.